A 20-Year Follow-up After First-Generation Autologous Chondrocyte Implantation

Abstract

First-generation ACI provided satisfactory survival rates and significant clinical improvements over a 20-year follow-up, which offers an important standard for comparison with newer-generation ACI technologies of the future.